|
1
|
Yamakuchi M and Lowenstein CJ: MiR-34,
SIRT1 and p53: the feedback loop. Cell Cycle. 8:712–715. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rokhlin OW, Scheinker VS, Taghiyev AF,
Bumcrot D, Glover RA and Cohen MB: MicroRNA-34 mediates
AR-dependent p53-induced apoptosis in prostate cancer. Cancer Biol
Ther. 7:1288–1296. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Paris R, Henry RE, Stephens SJ, McBryde M
and Espinosa JM: Multiple p53-independent gene silencing mechanisms
define the cellular response to p53 activation. Cell Cycle.
7:2427–2433. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mert U, Ozgür E, Tiryakioglu D, Dalay N
and Gezer U: Induction of p53-inducible microRNA miR-34 by gamma
radiation and bleomycin are different. Front Genet. 3:2202012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yamakuchi M, Ferlito M and Lowenstein CJ:
miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci
USA. 105:13421–13426. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tazawa H, Tsuchiya N, Izumiya M and
Nakagama H: Tumor-suppressive miR-34a induces senescence-like
growth arrest through modulation of the E2F pathway in human colon
cancer cells. Proc Natl Acad Sci USA. 104:15472–15477. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
He X, He L and Hannon GJ: The guardian’s
little helper: microRNAs in the p53 tumor suppressor network.
Cancer Res. 67:11099–11101. 2007.
|
|
8
|
Tarasov V, Jung P, Verdoodt B, et al:
Differential regulation of microRNAs by p53 revealed by massively
parallel sequencing: miR-34a is a p53 target that induces apoptosis
and G1-arrest. Cell Cycle. 6:1586–1593. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kumamoto K, Spillare EA, Fujita K, et al:
Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2
and up-regulate mir-34a, mir-34b, and mir-34c expression, and
induce senescence. Cancer Res. 68:3193–3203. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He L, He X, Lim LP, et al: A microRNA
component of the p53 tumour suppressor network. Nature.
447:1130–1134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Navarro F, Gutman D, Meire E, et al:
miR-34a contributes to megakaryocytic differentiation of K562 cells
independently of p53. Blood. 114:2181–2192. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li L, Wu J, Sima X, et al: Interactions of
miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal
carcinoma. Tumour Biol. 34:1919–1923. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ji Q, Hao X, Meng Y, et al: Restoration of
tumor suppressor miR-34 inhibits human p53-mutant gastric cancer
tumorspheres. BMC Cancer. 8:2662008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ji Q, Hao X, Zhang M, et al: MicroRNA
miR-34 inhibits human pancreatic cancer tumor-initiating cells.
PLoS One. 4:e68162009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pang Y, Young CY and Yuan H: MicroRNAs and
prostate cancer. Acta Biochim Biophys Sin (Shanghai). 42:363–369.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dalgard CL, Gonzalez M, deNiro JE and
O’Brien JM: Differential microRNA-34a expression and tumor
suppressor function in retinoblastoma cells. Invest Ophthalmol Vis
Sci. 50:4542–4551. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zenz T, Mohr J, Eldering E, et al: miR-34a
as part of the resistance network in chronic lymphocytic leukemia.
Blood. 113:3801–3808. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang J, Liu L, Xie L, Xiang G and Zhou Y:
Induction of differentiation-specific miRNAs in TPA-induced myeloid
leukemia cells through MEK/ERK activation. Int J Mol Med. 31:59–66.
2013.PubMed/NCBI
|
|
19
|
Vissers MC, Jester SA and Fantone JC:
Rapid purification of human peripheral blood monocytes by
centrifugation through Ficoll-Hypaque and Sepracell-MN. J Immunol
Methods. 110:203–207. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rücker FG, Russ AC, Cocciardi S, et al:
Altered miRNA and gene expression in acute myeloid leukemia with
complex karyotype identify networks of prognostic relevance.
Leukemia. 27:353–361. 2013.PubMed/NCBI
|
|
21
|
Visone R and Croce CM: MiRNAs and cancer.
Am J Pathol. 174:1131–1138. 2009. View Article : Google Scholar
|
|
22
|
Kelly L, Bryan K, Kim SY, et al:
Post-transcriptional dysregulation by miRNAs is implicated in the
pathogenesis of gastrointestinal stromal tumor [GIST]. PLoS One.
8:e641022013.PubMed/NCBI
|
|
23
|
Tuccoli A, Poliseno L and Rainaldi G:
miRNAs regulate miRNAs: coordinated transcriptional and
post-transcriptional regulation. Cell Cycle. 5:2473–2476. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Isken F, Steffen B, Merk S, et al:
Identification of acute myeloid leukaemia associated microRNA
expression patterns. Br J Haematol. 140:153–161. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Garzon R, Heaphy CE, Havelange V, et al:
MicroRNA 29b functions in acute myeloid leukemia. Blood.
114:5331–5341. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun F, Fu H, Liu Q, et al: Downregulation
of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett.
582:1564–1568. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tivnan A, Tracey L, Buckley PG, Alcock LC,
Davidoff AM and Stallings RL: MicroRNA-34a is a potent tumor
suppressor molecule in vivo in neuroblastoma. BMC Cancer.
11:332011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pilotti S, Della Torre G, Mezzelani A, et
al: The expression of MDM2/CDK4 gene product in the differential
diagnosis of well differentiated liposarcoma and large deep-seated
lipoma. Br J Cancer. 82:1271–1275. 2000.PubMed/NCBI
|
|
29
|
Dong Y, Sui L, Sugimoto K, Tai Y and
Tokuda M: Cyclin D1-CDK4 complex, a possible critical factor for
cell proliferation and prognosis in laryngeal squamous cell
carcinomas. Int J Cancer. 95:209–215. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Weber BL, Westin EH and Clarke MF:
Differentiation of mouse erythroleukemia cells enhanced by
alternatively spliced c-MYB mRNA. Science. 249:1291–1293. 1990.
View Article : Google Scholar : PubMed/NCBI
|
